Treatment of palmoplantar psoriasis with oral roflumilast: a case series

被引：0

作者：

Lasheras-Perez, Miguel Antonio ^{[1
,2
]}

Penuelas-Leal, Rodrigo ^{[3
]}

Sanchez-Carazo, Jose Luis ^{[3
]}

Sahuquillo-Torralba, Antonio Javier ^{[1
,2
]}

Magdaleno-Tapial, Jorge ^{[3
]}

Torres-Navarro, Ignacio ^{[1
,2
]}

Unamuno-Bustos, Blanca ^{[1
,2
]}

Lopez-Davia, Javier ^{[1
,2
]}

Pujol-Marco, Conrad ^{[1
,2
]}

Escutia-Munoz, Begona ^{[1
,2
]}

Botella-Estrada, Rafael ^{[1
,2
,4
]}

机构：

[1] La Fe Univ & Polytech Hosp, Dept Dermatol, Valencia, Spain

[2] Hlth Res Inst Hosp, La Valencia, Spain

[3] Valencia Gen Hosp, Dept Dermatol, Valencia, Spain

[4] Univ Valencia, Dept Dermatol, Valencia, Spain

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2024年

关键词：

D O I：

10.1093/ced/llae229

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Palmoplantar psoriasis (PP) is a particular type of psoriasis that can justify systemic treatment. Roflumilast is a targeted inhibitor of phosphodiesterase-4 that has been recently approved by the US Food and Drugs Administration as a cream for the treatment of plaque psoriasis. In a small randomized clinical trial and single case reports, oral roflumilast has demonstrated efficacy in the treatment of plaque psoriasis. To the best of our knowledge, we present the first case series of patients with PP treated with oral roflumilast.

引用

页数：3

共 50 条

[21] Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting
Reolid, Alejandra
Armesto, Susana
Sahuquillo-Torralba, Antonio
Torres, Tiago
Feltes, Rosa
Vilarrasa, Eva
Belinchon, Isabel
de la Cueva, Pablo
Rodriguez, Lourdes
Romero-Mate, Alberto
Vidal, David
Coto-Segura, Pablo
Herrera-Acosta, Enrique
Riera-Monroig, Josep
Salgado, Laura
Llamas-Velasco, Mar
Dauden, Esteban
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : 705 - 709
[22] Anti-tumor Necrosis Factor-induced Palmoplantar Psoriasis: Case Series
Altalhab, Saad
JOURNAL OF DERMATOLOGY DERMATOLOGIC SURGERY-JDDS, 2018, 22 (01): : 36 - 38
[23] Apremilast/InfliximabGeneralised pustular psoriasis, palmoplantar pustulosis and treatment noncompliance: case report
Reactions Weekly, 2025, 2040 (1) : 114 - 114
[24] Successful treatment of recalcitrant palmoplantar psoriasis with etanercept
Weinberg, JM
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P143 - P143
[25] Mepolizumab induced palmoplantar psoriasis: A case report
Artosi, Fabio
Diluvio, Laura
Vultaggio, Martina
Campione, Elena
Bianchi, Luca
WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (26) : 6154 - 6158
[26] Alefacept in the treatment of recalcitrant palmoplantar and erythrodermic psoriasis
Prossick, Trisha A.
Belsito, Donald V.
CUTIS, 2006, 78 (03): : 178 - 180
[27] Efficacy of Bath PUVA Treatment in Palmoplantar Psoriasis
Seckin, Dilek
Yazici, Zueleyha
Ergun, Tuelin
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 (01): : 25 - 28
[28] PembrolizumabPlaque psoriasis and palmoplantar pustulosis: case report
Reactions Weekly, 2024, 2035 (1) : 418 - 418
[29] A retrospective review of treatment response of palmoplantar psoriasis
Hecht, Abigail L.
Milani-Nejad, Nima
Bubic, Bianka N.
Kaffenberger, Jessica A.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (08) : E449 - E450
[30] AdalimumabExacerbation of psoriasis and palmoplantar hyperkeratosis: case report
Reactions Weekly, 2014, 1504 (1) : 5 - 5

← 1 2 3 4 5 →